A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats.

@article{Hoelmkjaer2016APS,
  title={A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats.},
  author={Kirsten Madsen Hoelmkjaer and Nicolai J Wewer Albrechtsen and Jens Juul Holst and Anna M Cronin and Dorte H. Nielsen and Thomas Mandrup-Poulsen and Charlotte Reinhard Bjornvad},
  journal={PloS one},
  year={2016},
  volume={11 5},
  pages={e0154727}
}
Glucagon-like Peptide-1 mimetics increase insulin secretion and reduces body weight in humans. In lean, healthy cats, short-term treatment has produced similar results, whereas the effect in obese cats or with extended duration of treatment is unknown. Here, prolonged (12 weeks) treatment with the Glucagon-like Peptide-1 mimetic, exenatide, was evaluated in… CONTINUE READING